Also listed on Trovis Pharmaceuticals, LLC, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Dec 11, 2027 · High confidence
20-year base term ended Feb 27, 2026
Held by Allergan Sales, LLC
Filed Feb 27, 2006 as application 11/362,390 · Granted Oct 6, 2009
Base term plus 652 days of patent term adjustment (USPTO delay)
Today
2006
2027
Clock starts
Feb 27, 2006
Feb 27, 2006
Term ends
Dec 11, 2027
Dec 11, 2027
Granted
Oct 6, 2009
Oct 6, 2009
base term
patent term adjustment
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
652
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 652 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 27, 2006, when this application, 11/362,390, was filed | Feb 27, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +652 days, USPTO patent term adjustment record | Dec 11, 2027 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Dec 11, 2027 | High confidence |
This family
| US 7,598,379 | this patent Dec 2027 | Dec 2027 |
| US 8,420,813 | Lapsed on the fee record Apr 2025 | Apr 2025 |
| US 8,501,941 | Lapsed on the fee record Aug 2025 | Aug 2025 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 20, 2007 Reel 19198, frame 496 | Rieger, Jayson M.; Thompson, Robert D.; Wang, Guoquan | Adenosine Therapeutics, LLC | Assignment of Assignor's Interest |
| Jan 8, 2009 Reel 22075, frame 734 | Adenosine Therapeutics, LLC | Pgxhealth, LLC | Assignment of Assignor's Interest |
| Jan 28, 2011 Reel 25709, frame 994 | Pgxhealth, LLC | Trovis Pharmaceuticals, LLC | Change of Name |
| Jan 24, 2013 Reel 29688, frame 503 | Trovis Pharmaceuticals LLC | Trovis Pharmaceuticals Holdings, Inc. | Merger |
| Jan 25, 2013 Reel 29694, frame 831 | Trovis Pharmaceuticals Holdings, Inc. | Clinical Data, Inc. | Merger |
| Feb 1, 2013 Reel 29737, frame 130 | Forest Laboratories Holdings Limited | Dogwood Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Feb 1, 2013 Reel 29736, frame 958 | Clinical Data, Inc. | Dogwood Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Feb 1, 2013 Reel 29737, frame 43 | Dogwood Pharmaceuticals, Inc. | Forest Laboratories Holdings Limited | Assignment of Assignor's Interest |
| Mar 19, 2013 Reel 30045, frame 915 | Forest Laboratories Holdings Limited | Dogwood Pharmaceuticals, Inc. | Corrective Assignment to Correct the Execution Date of the Previously Recorded Assignment from December 31, 2011 to March 15, 2013 Previously Recorded on Reel 029737 Frame 0130. Assignor(S) Hereby Confirms the the Execution Date of the Original Assignment Was Incorrectly Dated December 31, 2011. |
| Jun 26, 2018 Reel 46208, frame 691 | Dogwood Pharmaceuticals, Inc. | Allergan Sales, LLC | Merger |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Dec 2027
Term ends Dec 11, 2027. No further fees fall due before then
Note
The 652 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
10
later US patents cite this one
That is below the median of utility patents granted in 2009 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.